BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 26602841)

  • 21. Neuroendocrine Carcinoma of Gall Bladder: A Series of 19 Cases with Review of Literature.
    Kamboj M; Gandhi JS; Gupta G; Sharma A; Pasricha S; Mehta A; Chandragouda D; Sinha R
    J Gastrointest Cancer; 2015 Dec; 46(4):356-64. PubMed ID: 26208508
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Resection of Borderline Resectable and Locally Advanced Pancreatic Adenocarcinomas after Neoadjuvant Chemotherapy.
    Addeo P; Rosso E; Fuchshuber P; Oussoultzoglou E; De Blasi V; Simone G; Belletier C; Dufour P; Bachellier P
    Oncology; 2015; 89(1):37-46. PubMed ID: 25766660
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Surgery and staging of pancreatic neuroendocrine tumors: a 14-year experience.
    Ito H; Abramson M; Ito K; Swanson E; Cho N; Ruan DT; Swanson RS; Whang EE
    J Gastrointest Surg; 2010 May; 14(5):891-8. PubMed ID: 20224984
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radical antegrade modular pancreatosplenectomy for all pancreatic body and tail tumors: rationale and results.
    Sivasanker M; Desouza A; Bhandare M; Chaudhari V; Goel M; Shrikhande SV
    Langenbecks Arch Surg; 2019 Mar; 404(2):183-190. PubMed ID: 30790046
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Three-year and five-year outcomes of surgical resection for pancreatic ductal adenocarcinoma: Long-term experiences in one medical center.
    Hsu CP; Hsu JT; Liao CH; Kang SC; Lin BC; Hsu YP; Yeh CN; Yeh TS; Hwang TL
    Asian J Surg; 2018 Mar; 41(2):115-123. PubMed ID: 28010955
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Surgical resection of the primary tumor leads to prolonged survival in metastatic pancreatic neuroendocrine carcinoma.
    Feng T; Lv W; Yuan M; Shi Z; Zhong H; Ling S
    World J Surg Oncol; 2019 Mar; 17(1):54. PubMed ID: 30898132
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Survival following resection of pancreatic endocrine tumors: importance of R-status and the WHO and TNM classification systems.
    Pomianowska E; Gladhaug IP; Grzyb K; Røsok BI; Edwin B; Bergestuen DS; Mathisen O
    Scand J Gastroenterol; 2010 Aug; 45(7-8):971-9. PubMed ID: 20441530
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical importance of intraoperative peritoneal cytology in patients with pancreatic cancer.
    Abe T; Ohuchida K; Endo S; Ookubo F; Mori Y; Nakata K; Miyasaka Y; Manabe T; Ohtsuka T; Nagai E; Oda Y; Nakamura M
    Surgery; 2017 Apr; 161(4):951-958. PubMed ID: 27939334
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic factors following curative resection for pancreatic adenocarcinoma: a population-based, linked database analysis of 396 patients.
    Lim JE; Chien MW; Earle CC
    Ann Surg; 2003 Jan; 237(1):74-85. PubMed ID: 12496533
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Survival comparison between primary hepatic neuroendocrine neoplasms and primary pancreatic neuroendocrine neoplasms and the analysis on prognosis-related factors.
    Li MX; Li QY; Xiao M; Wan DL; Chen XH; Zhou L; Xie HY; Zheng SS
    Hepatobiliary Pancreat Dis Int; 2019 Dec; 18(6):538-545. PubMed ID: 30981633
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic factors and survival after surgical resection of pancreatic neuroendocrine tumor with validation of established and modified staging systems.
    Benetatos N; Hodson J; Marudanayagam R; Sutcliffe RP; Isaac JR; Ayuk J; Shah T; Roberts KJ
    Hepatobiliary Pancreat Dis Int; 2018 Apr; 17(2):169-175. PubMed ID: 29576279
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Surgery after neoadjuvant chemotherapy for locally advanced extrapulmonary poorly differentiated neuroendocrine cancer.
    Lessing Y; Ben-Haim M; Lahat G; Nackache R; Klausner JM; Shmueli E; Lubezky N
    Am Surg; 2011 Aug; 77(8):1102-4. PubMed ID: 21944536
    [No Abstract]   [Full Text] [Related]  

  • 33. Concordance Between the Ki-67 Index Cutoff Value of 55% and Differentiation in Neuroendocrine Tumor and Neuroendocrine Carcinoma in Grade 3 Pancreatic Neuroendocrine Neoplasms.
    Shi H; Chen L; Zhang Q; Lin Y; Jiang C; Yao H; Hou X; Chen M; Lin R; Chen J
    Pancreas; 2020; 49(10):1378-1382. PubMed ID: 33122528
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nonfunctioning neuroendocrine pancreatic tumors: our experience and management.
    Nomura N; Fujii T; Kanazumi N; Takeda S; Nomoto S; Kasuya H; Sugimoto H; Yamada S; Nakao A
    J Hepatobiliary Pancreat Surg; 2009; 16(5):639-47. PubMed ID: 19365596
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neoadjuvant radiation followed by resection versus upfront resection for locally advanced pancreatic cancer patients: a propensity score matched analysis.
    Chen X; Liu G; Wang K; Chen G; Sun J
    Oncotarget; 2017 Jul; 8(29):47831-47840. PubMed ID: 28599299
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Can the new RCP R0/R1 classification predict the clinical outcome in ductal adenocarcinoma of the pancreatic head?
    Janot MS; Kersting S; Belyaev O; Matuschek A; Chromik AM; Suelberg D; Uhl W; Tannapfel A; Bergmann U
    Langenbecks Arch Surg; 2012 Aug; 397(6):917-25. PubMed ID: 22695970
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of World Health Organization 2000/2004 and World Health Organization 2010 classifications for gastrointestinal and pancreatic neuroendocrine tumors.
    Pasaoglu E; Dursun N; Ozyalvacli G; Hacihasanoglu E; Behzatoglu K; Calay O
    Ann Diagn Pathol; 2015 Apr; 19(2):81-7. PubMed ID: 25702616
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-functional neuroendocrine carcinoma of the pancreas: incidence, tumor biology, and outcomes in 2,158 patients.
    Franko J; Feng W; Yip L; Genovese E; Moser AJ
    J Gastrointest Surg; 2010 Mar; 14(3):541-8. PubMed ID: 19997980
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Results after surgical treatment of liver metastases in patients with high-grade gastroenteropancreatic neuroendocrine carcinomas.
    Galleberg RB; Knigge U; Tiensuu Janson E; Vestermark LW; Haugvik SP; Ladekarl M; Langer SW; Grønbæk H; Österlund P; Hjortland GO; Assmus J; Tang L; Perren A; Sorbye H
    Eur J Surg Oncol; 2017 Sep; 43(9):1682-1689. PubMed ID: 28522174
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic factors for survival after extended pancreatectomy for pancreatic head cancer: influence of resection margin status on survival.
    Kato K; Yamada S; Sugimoto H; Kanazumi N; Nomoto S; Takeda S; Kodera Y; Morita S; Nakao A
    Pancreas; 2009 Aug; 38(6):605-12. PubMed ID: 19629002
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.